Together, these interventions provide comprehensive renoprotection by lowering apoptosis (reduced BAX and increased BCL-2) and suppressing TGF-β-driven fibrosis, thereby preserving renal integrity and preventing long-term damage in DN. The gene discussed is BAX; the disease is liver dysplastic nodule.